✦ LIBER ✦

Circulating β-carotene levels and type 2 diabetes—cause or effect?

✍ Scribed by J. R. B. Perry; L. Ferrucci; S. Bandinelli; J. Guralnik; R. D. Semba; N. Rice; D. Melzer; the DIAGRAM Consortium; R. Saxena; L. J. Scott; M. I. McCarthy; A. T. Hattersley; E. Zeggini; M. N. Weedon; T. M. Frayling

Book ID: 105819578
Publisher: Springer
Year: 2009
Tongue: English
Weight: 121 KB
Volume: 52
Category: Article
ISSN: 0012-186X
DOI: 10.1007/s00125-009-1475-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of α-tocopherol and β-carotene su

Effect of α-tocopherol and β-carotene supplementation on the incidence of type 2 diabetes

✍ M. Kataja-Tuomola; J. R. Sundell; S. Männistö; M. J. Virtanen; J. Kontto; D. Alb 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 146 KB

Circulating obestatin levels in normal s

Circulating obestatin levels in normal subjects and in patients with impaired glucose regulation and type 2 diabetes mellitus

✍ Xiaoya Qi; Ling Li; Gangyi Yang; Jianlei Liu; Ke Li; Yi Tang; Hua Liou; Guenther 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Circulating levels of free insulin-like

Circulating levels of free insulin-like growth factors in obese subjects: the impact of Type 2 diabetes

✍ J. Frystyk; C. Skjærbæk; E. Vestbo; S. Fisker; H. Ørskov 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

Circulating vascular endothelial growth

Circulating vascular endothelial growth factor in the normo- and/or microalbuminuric patients with type 2 diabetes mellitus

✍ Peter Kubisz; Peter Chudý; Ján Staško; Peter Galajda; Pavol Hollý; Robert Vyšehr 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 209 KB

Effect of sitagliptin therapy on postpra

Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes

✍ A. J. Tremblay; B. Lamarche; C. F. Deacon; S. J. Weisnagel; P. Couture 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 634 KB

Effect of metformin on bile salt circula

Effect of metformin on bile salt circulation and intestinal motility in Type 2 diabetes mellitus

✍ Scarpello, J.H.B.; Hodgson, E.; Howlett, H.C.S. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 2 views

Gastrointestinal symptoms can be a limiting factor in optimizing metformin therapy, particularly at the onset of treatment. The underlying cause remains unclear. We have investigated whether metformin changes oral-caecal transit and if it causes bile salt malabsorption using the lactulose breath tes